Extending the Treatment Window for Intravenous Thrombolysis in Acute Ischemic Stroke: An Updated Systematic Review and Meta-Analysis

Расширение терапевтического окна для внутривенного тромболизиса при остром ишемическом инсульте: обновлённый систематический обзор и метаанализ
Soheil Rahmati, Mohammadreza Alinejadfard, Yasaman Zarinfar, Amir Moradi, Amir Ghabousian, Ali Moradi, Kimia Najafi, Fady Iskander, Azeem Latib, Toshiki Kuno, Preethi Ramchand, Kaveh Hosseini
2026-09-11

acute ischemic strokeextended treatment windowimaging-based selectionintravenous thrombolysistenecteplase
BACKGROUND AND OBJECTIVES: Intravenous thrombolysis (IVT) is the standard treatment for acute ischemic stroke within 4.5 hours of onset. However, imaging-based selection may extend the treatment window. This systematic review and meta-analysis evaluated the efficacy and safety of IVT administered beyond 4.5 hours after stroke onset or last known well (LKW) in patients selected based on imaging findings. METHODS: A comprehensive search of PubMed, Scopus, and Cochrane Library was performed to identify randomized controlled trials comparing IVT with alteplase or tenecteplase (TNK) administered >4.5 hours after stroke onset/LKW vs standard care. Primary outcomes were 3-month excellent (modified Rankin Scale [mRS] 0-1) functional outcome and symptomatic intracranial hemorrhage (sICH). Secondary outcomes included good (mRS 0-2) functional outcome, recanalization, and 3-month mortality. Pooled odds ratios (ORs) with 95% confidence intervals (CIs) were calculated using random-effects models. Subgroup analysis assessed differences between alteplase and TNK. RESULTS: = 0.11). DISCUSSION: Among patients selected based on imaging, 4.5-24 hours after stroke onset/LKW, IVT improves outcomes despite an increased risk of sICH. TNK showed similar efficacy to alteplase, with a possible lower risk of sICH; however, direct comparisons in future trials are needed.
1
Delayed intravenous thrombolysis was associated with an increased risk of symptomatic intracranial hemorrhage.
2
Imaging-based selection enabled evaluation of intravenous thrombolysis administered 4.5–24 hours after stroke onset or last known well.
3
In imaging-selected patients, delayed intravenous thrombolysis improved 3-month functional outcomes compared with standard care.
4
Tenecteplase showed similar efficacy to alteplase and a possible lower symptomatic intracranial hemorrhage risk, requiring direct comparative trials.
5
The abstract reports a randomized-trial systematic review and meta-analysis using pooled odds ratios with random-effects models.

Imaging-selected patients with acute ischemic stroke treated with intravenous thrombolysis beyond 4.5 hours after stroke onset or last known well

The efficacy and safety of extended-window intravenous thrombolysis, including functional outcomes, symptomatic intracranial hemorrhage, recanalization, and mortality, with comparison of alteplase and tenecteplase

Publication Details
Publication Date
2026-09-11
Journal
Publisher
ISSN
Access Type
Author Information
Authors
Soheil Rahmati
Mohammadreza Alinejadfard
Yasaman Zarinfar
Amir Moradi
Amir Ghabousian
Ali Moradi
Kimia Najafi
Fady Iskander
Azeem Latib
Toshiki Kuno
Preethi Ramchand
Kaveh Hosseini
Explore further
Open the scid.ai AI chat with a ready-made request: it will find papers on a similar topic and help build a literature review.
Find similar papers in the chat →
Make a presentation
100%